BIONOVATE TECHNOLOGIES CORP. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a18bbb01-58fc-4c82-8c1d-d091fb598b83/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $0 | 2020-07-01 – 2021-06-30 | evidence 0001640334-21-002564 |
| FY 2020 | $0 | 2019-07-01 – 2020-06-30 | evidence 0001640334-20-002607 |
| FY 2019 | $0 | 2018-07-01 – 2019-06-30 | evidence 0001640334-20-002607 |
| FY 2017 | $5.4k | 2016-07-01 – 2017-06-30 | evidence 0001640334-18-001270 |
| FY 2016 | $110.8k | 2010-07-19 – 2016-09-30 | evidence 0001062993-16-012127 |
| FY 2015 | $102.7k | 2010-07-19 – 2016-03-31 | evidence 0001062993-16-009546 |
| FY 2014 | $99.4k | 2010-07-19 – 2015-03-31 | evidence 0001062993-15-002651 |
| FY 2013 | $92.3k | 2010-07-19 – 2014-03-31 | evidence 0001062993-14-002720 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
BIONOVATE TECHNOLOGIES CORP. — all facts · Net Income · Operating Income